Charles River Associates publishes CRA Insights, a newsletter highlighting recent thinking and announcements from members of our Life Sciences Practice.
CRA leading the way in analytics
In recent years, the adoption of advanced treatments in inflammatory bowel disease has evolved. Oral products have captured a significant share in ulcerative...